Robert Burger

UNVERIFIED PROFILE

Are you Robert Burger?   Register this Author

Register author

Robert Burger

Publications by authors named "Robert Burger"

Are you Robert Burger?   Register this Author

91Publications

-Reads

Are patients willing to travel for better ovarian cancer care?

Gynecol Oncol 2018 01 1;148(1):42-48. Epub 2017 Nov 1.

Division of General Internal Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA and the Center for Health Equity Research and Promotion (CHERP), Philadelphia VA Medical Center, Philadelphia, PA, United States.

View Article
January 2018

Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses.

J Natl Cancer Inst 2017 Nov;109(11)

Genentech Inc., South San Francisco, CA; F Hoffmann-La Roche Ltd, Basel, Switzerland; NRG Statistical and Data Center, Roswell Park Cancer Institute, Buffalo, NY; University of Oklahoma, Oklahoma City, OK; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, PA; Center for Cancer Research, Gillette Center for Gynecologic Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; HistoGeneX NV, Antwerp, Belgium; Division of Physiopharmacology, University of Antwerp, Antwerp, Belgium.

View Article
November 2017

Wide-Scope Screening Method for Multiclass Veterinary Drug Residues in Fish, Shrimp, and Eel Using Liquid Chromatography-Quadrupole High-Resolution Mass Spectrometry.

J Agric Food Chem 2017 Aug 13;65(34):7252-7267. Epub 2017 Jan 13.

Animal Drugs Research Center, U.S. Food and Drug Administration , Denver, Colorado 80225, United States.

View Article
August 2017

Readmission After Gynecologic Surgery: A Comparison of Procedures for Benign and Malignant Indications.

Obstet Gynecol 2017 08;130(2):285-295

University of Pennsylvania, Philadelphia, and the Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania.

View Article
August 2017

Incidence of Venous Thromboembolism by Type of Gynecologic Malignancy and Surgical Modality in the National Surgical Quality Improvement Program.

Int J Gynecol Cancer 2017 03;27(3):581-587

*Division of Gynecologic Oncology, University of Pennsylvania Health System, Philadelphia; and †Department of Public Health Sciences, Pennsylvania State University, Hershey, PA; and ‡Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

View Article
March 2017

Lab-on-a-disc agglutination assay for protein detection by optomagnetic readout and optical imaging using nano- and micro-sized magnetic beads.

Biosens Bioelectron 2016 Nov 7;85:351-357. Epub 2016 May 7.

Department of Micro and Nanotechnology, Technical University of Denmark, DTU Nanotech, Building 345 East, DK-2800 Kongens Lyngby, Denmark.

View Article
November 2016

Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.

J Clin Oncol 2016 Nov;34(32):3854-3863

Larissa A. Meyer, Charlotte C. Sun, and Charles F. Levenback, The University of Texas MD Anderson Cancer Center, Houston, TX; Angel M. Cronin, Ursula A. Matulonis, and Alexi A. Wright, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA; Kristin Bixel and David M. O'Malley, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Michael A. Bookman, US Oncology Research and Arizona Oncology, Tucson, AZ; Mihaela C. Cristea and Joyce C. Niland, City of Hope Comprehensive Cancer Center, Duarte, CA; Jennifer J. Griggs, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Robert A. Burger, University of Pennsylvania; and Gina Mantia-Smaldone, Fox Chase Cancer Center, Philadelphia, PA.

View Article
November 2016

Race-based disparities in loss of functional independence after hysterectomy for uterine cancer.

Support Care Cancer 2016 08 30;24(8):3573-80. Epub 2016 Mar 30.

Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

View Article
August 2016

Detection methods for centrifugal microfluidic platforms.

Biosens Bioelectron 2016 Feb 2;76:54-67. Epub 2015 Jul 2.

Department of Micro- and Nanotechnology, Technical University of Denmark, DK-2800 Kgs. Lyngby, Denmark.

View Article
February 2016

Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (GOG 218): an NRG oncology/gynecologic oncology group study (ADS-1236).

Gynecol Oncol 2015 Nov 1;139(2):221-7. Epub 2015 Sep 1.

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Pennsylvania, 3400 Civic Center Boulevard, SCTR 8-104 Philadelphia PA, United States. Electronic address:

View Article
November 2015

Quantification of NS1 dengue biomarker in serum via optomagnetic nanocluster detection.

Sci Rep 2015 Nov 5;5:16145. Epub 2015 Nov 5.

Department of Micro- and Nanotechnology, Technical University of Denmark, DTU Nanotech, Building 345 East, DK-2800 Kgs. Lyngby, Denmark.

View Article
November 2015

Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer.

J Clin Oncol 2015 Sep 3;33(26):2841-7. Epub 2015 Aug 3.

Alexi A. Wright, Angel Cronin, Dana E. Milne, Nancy L. Keating, Ursula A. Matulonis, and Jane C. Weeks, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA; Michael A. Bookman, University of Arizona Cancer Center, Tucson, AZ; Robert A. Burger, University of Pennsylvania; Gina Mantia-Smaldone, Fox Chase Cancer Center, Philadelphia, PA; David E. Cohn and David M. O'Malley, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Mihaela Cristea and Joyce C. Niland, City of Hope Comprehensive Cancer Center, Duarte, CA; Jennifer J. Griggs, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; and Charles F. Levenback and Larissa A. Meyer, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article
September 2015

Quantification of rolling circle amplified DNA using magnetic nanobeads and a Blu-ray optical pick-up unit.

Biosens Bioelectron 2015 May 6;67:649-55. Epub 2014 Oct 6.

Department of Micro- and Nanotechnology, Technical University of Denmark, DTU Nanotech, Building 345 East, DK-2800 Kgs. Lyngby, Denmark. Electronic address:

View Article
May 2015

Real-time monitoring of cell migration, phagocytosis and cell surface receptor dynamics using a novel, live-cell opto-microfluidic technique.

Anal Chim Acta 2015 May 26;872:95-9. Epub 2014 Dec 26.

Biomedical Diagnostics Institute, National Centre for Sensor Research, Dublin City University, Glasnevin, Dublin 9, Ireland; School of Physical Sciences, National Centre for Sensor Research, Dublin City University, Glasnevin, Dublin 9, Ireland. Electronic address:

View Article
May 2015

Analysis of sulfonamides, trimethoprim, fluoroquinolones, quinolones, triphenylmethane dyes and methyltestosterone in fish and shrimp using liquid chromatography-mass spectrometry.

J Chromatogr B Analyt Technol Biomed Life Sci 2014 Dec 16;972:38-47. Epub 2014 Sep 16.

Animal Drugs Research Center, U.S. Food and Drug Administration, Denver Federal Center, P.O. Box 25087, Denver, CO 80225-0087, United States; Denver Laboratory, U.S. Food and Drug Administration, Denver Federal Center, P.O. Box 25087, Denver, CO 80225-0087, United States.

View Article
December 2014

American Society of Clinical Oncology position statement on obesity and cancer.

J Clin Oncol 2014 Nov 1;32(31):3568-74. Epub 2014 Oct 1.

Jennifer A. Ligibel, Dana-Farber Cancer Institute, Boston, MA; Catherine M. Alfano, National Cancer Institute, Bethesda, MD; Kerry S. Courneya, University of Alberta, Edmonton, Alberta, Canada; Wendy Demark-Wahnefried, University of Alabama at Birmingham, Birmingham, AL; Robert A. Burger, University of Pennsylvania, Philadelphia, PA; Rowan T. Chlebowski, Harbor-University of California Los Angeles Medical Center, Torrance, CA; Carol J. Fabian, University of Kansas Medical Center, Westwood, KS; Ayca Gucalp, Lee W. Jones, and Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center; Dawn L. Hershman, Columbia University Medical Center, New York, NY; Melissa M. Hudson and Kirsten K. Ness, St Jude Children's Research Hospital, Memphis, TN; Madhuri Kakarala, Van Andel Institute, Grand Rapids, MI; and Janette K. Merrill and Dana S. Wollins, American Society of Clinical Oncology, Alexandria, VA.

View Article
November 2014

A portable centrifugal analyser for liver function screening.

Biosens Bioelectron 2014 Jun 27;56:352-8. Epub 2014 Jan 27.

Biomedical Diagnostics Institute, National Centre for Sensor Research, Dublin City University, Ireland; School of Physical Sciences, Dublin City University, Ireland.

View Article
June 2014

Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study.

J Clin Oncol 2014 Apr 17;32(12):1210-7. Epub 2014 Mar 17.

Robert A. Burger, Fox Chase Cancer Center, Philadelphia, PA; Mark F. Brady, GOG Statistical and Data Center, Buffalo, NY; Michael A. Bookman, Arizona Cancer Center, Tucson, AZ; Bradley J. Monk, University of California at Irvine, Orange, CA; Joan L. Walker, University of Oklahoma, Oklahoma City, OK; Howard D. Homesley, Wake Forest University Medical Center, Winston-Salem, NC; Jeffrey Fowler, Ohio State University, Columbus, OH; Benjamin E. Greer, University of Washington Medical Center, Seattle, WA; Matthew Boente, Minnesota Oncology Hematology, Minneapolis, MN; Gini F. Fleming, University of Chicago, Chicago, IL; Peter C. Lim, Center of Hope at Renown Regional Medical Center, Reno, NV; Stephen C. Rubin, University of Pennsylvania Cancer Center, Philadelphia, PA; Noriyuki Katsumata, Saitama Medical University/International Medical Center-GOG Japan, Saitama, Japan; and Sharon X. Liang, North Shore University Hospital, Manhasset, NY.

View Article
April 2014

PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancer.

J Clin Oncol 2013 Dec 14;31(35):4400-6. Epub 2013 Oct 14.

R. Wendel Naumann and James T. Symanowski, Levine Cancer Institute, Carolinas Medical Center, Charlotte, NC; Robert L. Coleman, MD Anderson Cancer Center, University of Texas, Houston; Michael G. Teneriello, Texas Oncology, Austin, TX; Robert A. Burger, Fox Chase Cancer Center, Philadelphia, PA; Edward A. Sausville, Greenebaum Cancer Center, University of Maryland, Baltimore, MD; Elzbieta Kutarska, Centrum Onkologii Ziemi Lubelskiej, Lubland; Elzbieta Nowara, Instytut im. Marii Skłodowskiej-Curie, Gliwice, Poland; Sharad A. Ghamande, Georgia Health Sciences University, Augusta, GA; Nashat Y. Gabrail, Gabrail Cancer Center, Canton, OH; Stephen E. DePasquale, Chattanooga's Program in Women's Oncology, Chattanooga, TN; Lucy Gilbert, McGill University Health Centre, Montreal, Quebec, Canada; Robert H. Gersh, Cancer Care Northwest, Spokane, WA; Wael A. Harb, Horizon Oncology Research, Lafayette; Chandra D. Lovejoy, Christopher P. Leamon, David E. Morgenstern, and Richard A. Messmann, Endocyte, West Lafayette, IN; Panagiotis A. Konstantinopoulos, Beth Israel Deaconess Medical Center; and Richard T. Penson, Dana-Farber Cancer Center, Massachusetts General Hospital, Boston, MA.

View Article
December 2013

Ovarian cancer, version 2.2013.

J Natl Compr Canc Netw 2013 Oct;11(10):1199-209

From 1City of Hope Comprehensive Cancer Center; 2University of Alabama at Birmingham Comprehensive Cancer Center; 3The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 4Fox Chase Cancer Center; 5UCSF Helen Diller Family Comprehensive Cancer Center; 6he Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 7Vanderbilt-Ingram Cancer Center; 8The University of Texas MD Anderson Cancer Center; 9University of Washington/Seattle Cancer Care Alliance; 10Moffitt Cancer Center; 11Duke Cancer Institute; 12University of Michigan Comprehensive Cancer Center; 13Roswell Park Cancer Institute; 14Dana-Farber/Brigham and Women's Cancer Center; 15Massachusetts General Hospital Cancer Center; 16Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 17Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 18Memorial Sloan-Kettering Cancer Center; 19St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 20Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 21Stanford Cancer Institute; 22Huntsman Cancer Institute at the University of Utah; and 23National Comprehensive Cancer Network.

View Article
October 2013

Fluidic automation of nitrate and nitrite bioassays in whole blood by dissolvable-film based centrifugo-pneumatic actuation.

Sensors (Basel) 2013 Aug 26;13(9):11336-49. Epub 2013 Aug 26.

Biomedical Diagnostics Institute, National Centre for Sensor Research, School of Physical Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland.

View Article
August 2013

Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.

Gynecol Oncol 2013 Mar 4;128(3):573-8. Epub 2012 Dec 4.

Creighton University School of Medicine at St. Joseph's Hospital and Medical Center, Department of Obstetrics and Gynecologic Oncology, 500 W. Thomas Road, Suite 600, Phoenix, AZ 85013, USA.

View Article
March 2013

Comprehensive integration of homogeneous bioassays via centrifugo-pneumatic cascading.

Lab Chip 2013 Feb;13(4):685-94

Biomedical Diagnostics Institute, National Centre for Sensor Research, School of Physical Sciences, Dublin City University, Ireland.

View Article
February 2013

Cytokine use and survival in the first-line treatment of ovarian cancer: a Gynecologic Oncology Group Study.

Gynecol Oncol 2012 Dec 19;127(3):495-501. Epub 2012 Sep 19.

Indiana University School of Medicine, Indianapolis, IN 46202, USA.

View Article
December 2012

Centrifugal microfluidics for cell analysis.

Curr Opin Chem Biol 2012 Aug 9;16(3-4):409-14. Epub 2012 Jul 9.

Biomedical Diagnostics Institute, National Centre for Sensor Research, School of Physical Sciences, Dublin City University, Ireland.

View Article
August 2012

Handling and analysis of cells and bioparticles on centrifugal microfluidic platforms.

Expert Rev Mol Diagn 2012 May;12(4):407-21

Biomedical Diagnostics Institute, National Centre for Sensor Research, School of Physical Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland.

View Article
May 2012

Array-based capture, distribution, counting and multiplexed assaying of beads on a centrifugal microfluidic platform.

Lab Chip 2012 Apr 15;12(7):1289-95. Epub 2012 Feb 15.

Biomedical Diagnostics Institute, National Centre for Sensor Research, School of Physical Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland.

View Article
April 2012

Predictive value of serum CA-125 levels in patients with persistent or recurrent epithelial ovarian cancer or peritoneal cancer treated with bevacizumab on a Gynecologic Oncology Group phase II trial.

Gynecol Oncol 2012 Mar 1;124(3):563-8. Epub 2011 Dec 1.

Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, CA 92868, USA.

View Article
March 2012

Advances in ovarian cancer disease control.

Authors:
Robert A Burger

Gynecol Oncol 2012 Jan;124(1):5-9

View Article
January 2012

Overview of anti-angiogenic agents in development for ovarian cancer.

Authors:
Robert A Burger

Gynecol Oncol 2011 Apr 8;121(1):230-8. Epub 2011 Jan 8.

Department of Surgical Oncology, Section of Gynecologic Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111-2497, USA.

View Article
April 2011

Prospective evaluation of an in vitro radiation resistance assay in locally advanced cancer of the uterine cervix: a Southwest Oncology Group Study.

Gynecol Oncol 2010 Dec 16;119(3):417-21. Epub 2010 Sep 16.

Chao Family Comprehensive Cancer Center, University of California-Irvine Medical Center, Orange, CA 92868, USA.

View Article
December 2010

Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies.

Authors:
Robert A Burger

J Gynecol Oncol 2010 Mar 31;21(1):3-11. Epub 2010 Mar 31.

Department of Surgical Oncology, Section of Gynecologic Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

View Article
March 2010

Necrobacillosis resulting in isolated carotid thrombosis and massive stroke: a unique Lemierre variant?

J Neurol Sci 2009 Dec 4;287(1-2):108-10. Epub 2009 Sep 4.

Department of Neurology, University of Missouri Healthcare-Columbia, Columbia, Missouri, USA.

View Article
December 2009

Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.

Gynecol Oncol 2009 Mar 24;112(3):583-9. Epub 2008 Dec 24.

Chao Family Comprehensive Cancer Center, University of California-Irvine Medical Center, Orange, CA 92868, USA.

View Article
March 2009

Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study.

J Clin Oncol 2009 Mar 12;27(7):1069-74. Epub 2009 Jan 12.

University of California, Irvine Medical Center, Bldg 56, Room 262, 101 The City Dr, Orange, CA 92868. USA.

View Article
March 2009

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.

Gynecol Oncol 2009 Jan 1;112(1):85-9. Epub 2008 Nov 1.

Department of OB/GYN, Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, University of California-Irvine Medical Center, Orange, CA 92868, USA.

View Article
January 2009

Alginate bead fabrication and encapsulation of living cells under centrifugally induced artificial gravity conditions.

J Microencapsul 2008 Jun;25(4):267-74

HSG-IMIT-Institute for Micromachining and Information Technology, Villingen-Schwenningen, Germany.

View Article
June 2008

Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.

J Clin Oncol 2007 Nov;25(33):5165-71

University of California, Irvine Medical Center, Building 56, Room 264, 101 The City Dr, Orange, CA 92868, USA.

View Article
November 2007

Experience with bevacizumab in the management of epithelial ovarian cancer.

Authors:
Robert A Burger

J Clin Oncol 2007 Jul;25(20):2902-8

University of California, Irvine Medical Center, Irvine, Orange, CA 92868, USA.

View Article
July 2007

Salvage bevacizumab (rhuMAB VEGF)-based therapy after multiple prior cytotoxic regimens in advanced refractory epithelial ovarian cancer.

Gynecol Oncol 2006 Aug 21;102(2):140-4. Epub 2006 Jun 21.

Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, University of California-Irvine Medical Center, 1012 The City Drive, Orange, CA 92868, USA.

View Article
August 2006

Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study.

Gynecol Oncol 2005 Oct;99(1):71-9

Division of Gynecologic Oncology, University of Washington, Fred Hutchinson Cancer Research Center, Puget Sound Oncology Consortium LF-287, 1100 Fairview Avenue N., Seattle, WA 98109, USA.

View Article
October 2005

Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study.

Gynecol Oncol 2005 Oct;99(1):84-91

Division of Gynecologic Oncology, University of California Irvine Medical Center, 101 The City Drive South, Orange, CA 92868, USA.

View Article
October 2005

Conservation of in vitro drug resistance patterns in epithelial ovarian carcinoma.

Gynecol Oncol 2005 Sep;98(3):360-8

The Division of Gynecologic Oncology, The Chao Family Comprehensive Cancer Center, University of California, Irvine-Medical Center, 101 The City Drive, Orange, CA 92868, USA.

View Article
September 2005

Suppression of ovarian cancer cell tumorigenicity and evasion of Cisplatin resistance using a truncated epidermal growth factor receptor in a rat model.

Cancer Res 2005 Apr;65(8):3243-8

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford Cancer Center, 300 Pasteur Drive HH333, Stanford, CA 94305-5317, USA.

View Article
April 2005

Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer.

Gynecol Oncol 2005 Mar;96(3):902-5

Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine, Medical Center, 101 The City Drive, Building 56, Room 262, Orange CA 92868, USA.

View Article
March 2005

Gemcitabine and cisplatin chemotherapy is an active combination in the treatment of platinum-resistant ovarian and peritoneal carcinoma.

Invest New Drugs 2004 Nov;22(4):475-80

Chao Family Comprehensive Cancer Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine-Medical Center, 101 The City Drive, Orange, CA 92868, USA.

View Article
November 2004

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.

J Clin Oncol 2004 Oct;22(19):3902-8

Division of Oncology, Department of Medicine, University of Mississippi School of Medicine, Jackson, USA.

View Article
October 2004

Radical hysterectomy followed by tailored postoperative therapy in the treatment of stage IB2 cervical cancer: feasibility and indications for adjuvant therapy.

Gynecol Oncol 2004 Jul;94(1):61-6

Department of Obstetrics and Gynecology, Chao Family Comprehensive Cancer Center, University of California, Irvine-Medical Center, Orange, CA 92868, USA.

View Article
July 2004

Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion.

Clin Cancer Res 2003 Sep;9(11):4145-50

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chao Family Comprehensive Cancer Center, University of California-Irvine Medical Center, 101 The City Drive, Orange, CA 92868, USA.

View Article
September 2003

Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.

Cancer 2003 Feb;97(3):568-74

Division of Gynecologic Oncology, The Chao Family Comprehensive Cancer Center, University of California-Irvine Medical Center, Orange, California 92868, USA.

View Article
February 2003

Development of an in vitro chemo-radiation response assay for cervical carcinoma.

Gynecol Oncol 2002 Nov;87(2):193-9

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California, Irvine, Orange, California 92868, USA.

View Article
November 2002

Phase II evaluation of oral trimetrexate in mixed mesodermal tumors of the uterus: a gynecologic oncology group study.

Gynecol Oncol 2002 May;85(2):311-4

Division of Gynecologic Oncology, Ohio State University, Columbus, OH 43210, USA.

View Article
May 2002

Primary invasive vaginal cancer in the setting of the Mayer-Rokitansky-Kuster-Hauser syndrome.

Gynecol Oncol 2002 May;85(2):384-7

Division of Gynecologic Oncology, Division of Radiation Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, 101 The City Drive, Orange, CA 92868, USA.

View Article
May 2002

Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation.

Int J Radiat Oncol Biol Phys 2002 Mar;52(3):806-15

Division of Gynecologic Oncology, The Chao Family N.C.I.-Designated Comprehensive Cancer Center, University of California, Irvine-Medical Center, Orange, CA 92868, USA.

View Article
March 2002